Reply to J. David et al

Affiliations

¹ Jarad Martin, PhD, MD, University of Newcastle, Newcastle, New South Wales, Australia; Himu Lukka, MBBCh, McMaster University Hamilton, Ontario, Canada; and Charles Catton, MD, University of Toronto, Toronto, Ontario, Canada.

Comment

Jarad Martin et al. J Clin Oncol. 2019.

. 2019 Feb 10;37(5):441.

doi: 10.1200/JCO.18.01718. Epub 2018 Dec 28.

¹ Jarad Martin, PhD, MD, University of Newcastle, Newcastle, New South Wales, Australia; Himu Lukka, MBBCh, McMaster University Hamilton, Ontario, Canada; and Charles Catton, MD, University of Toronto, Toronto, Ontario, Canada.

No abstract available

Comment on

Prostate Cancer Radiotherapy: An Evolving Paradigm.
Catton CN, Lukka H, Martin J. Catton CN, et al. J Clin Oncol. 2018 Oct 10;36(29):2909-2913. doi: 10.1200/JCO.2018.79.3257. Epub 2018 Aug 23. J Clin Oncol. 2018. PMID: 30138084
Prostate Cancer Radiotherapy: An Evolving Paradigm That Should Also Include High-Dose-Rate Monotherapy.
David J, Kamrava M. David J, et al. J Clin Oncol. 2019 Feb 10;37(5):441. doi: 10.1200/JCO.18.01482. Epub 2018 Dec 28. J Clin Oncol. 2019. PMID: 30592643 No abstract available.